ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rofecoxib Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-7G3726
Home | Market Reports | Health| Pharmacy
Global Rofecoxib Market Insights Forecast to 2028
BUY CHAPTERS

Global Rofecoxib Market Insights, Forecast to 2030

Code: QYRE-Auto-7G3726
Report
December 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer Inc
Tremeau

Rofecoxib Market

Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Rofecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rofecoxib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rofecoxib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rofecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rofecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rofecoxib sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Rofecoxib Market Report

Report Metric Details
Report Name Rofecoxib Market
Segment by Type
  • Oral Suspension.
  • Tablet-Form
Segment by Application
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Juvenile Rheumatoid Arthritis
  • Acute Pain Conditions
  • Migraine
  • Dysmenorrhea
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer, Tremeau
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Rofecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rofecoxib sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rofecoxib Market report?

Ans: The main players in the Rofecoxib Market are Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer, Tremeau

What are the Application segmentation covered in the Rofecoxib Market report?

Ans: The Applications covered in the Rofecoxib Market report are Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Acute Pain Conditions, Migraine, Dysmenorrhea

What are the Type segmentation covered in the Rofecoxib Market report?

Ans: The Types covered in the Rofecoxib Market report are Oral Suspension., Tablet-Form

Recommended Reports

Pain Management Drugs

Arthritis Treatments

Specialty Pain Relief

1 Study Coverage
1.1 Rofecoxib Product Introduction
1.2 Market by Type
1.2.1 Global Rofecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Market by Application
1.3.1 Global Rofecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rofecoxib Sales Estimates and Forecasts 2019-2030
2.2 Global Rofecoxib Revenue by Region
2.2.1 Global Rofecoxib Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Rofecoxib Revenue by Region (2019-2024)
2.2.3 Global Rofecoxib Revenue by Region (2025-2030)
2.2.4 Global Rofecoxib Revenue Market Share by Region (2019-2030)
2.3 Global Rofecoxib Sales Estimates and Forecasts 2019-2030
2.4 Global Rofecoxib Sales by Region
2.4.1 Global Rofecoxib Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Rofecoxib Sales by Region (2019-2024)
2.4.3 Global Rofecoxib Sales by Region (2025-2030)
2.4.4 Global Rofecoxib Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rofecoxib Sales by Manufacturers
3.1.1 Global Rofecoxib Sales by Manufacturers (2019-2024)
3.1.2 Global Rofecoxib Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rofecoxib in 2023
3.2 Global Rofecoxib Revenue by Manufacturers
3.2.1 Global Rofecoxib Revenue by Manufacturers (2019-2024)
3.2.2 Global Rofecoxib Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2023
3.3 Global Key Players of Rofecoxib, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Rofecoxib Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rofecoxib, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rofecoxib, Product Offered and Application
3.8 Global Key Manufacturers of Rofecoxib, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rofecoxib Sales by Type
4.1.1 Global Rofecoxib Historical Sales by Type (2019-2024)
4.1.2 Global Rofecoxib Forecasted Sales by Type (2025-2030)
4.1.3 Global Rofecoxib Sales Market Share by Type (2019-2030)
4.2 Global Rofecoxib Revenue by Type
4.2.1 Global Rofecoxib Historical Revenue by Type (2019-2024)
4.2.2 Global Rofecoxib Forecasted Revenue by Type (2025-2030)
4.2.3 Global Rofecoxib Revenue Market Share by Type (2019-2030)
4.3 Global Rofecoxib Price by Type
4.3.1 Global Rofecoxib Price by Type (2019-2024)
4.3.2 Global Rofecoxib Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Rofecoxib Sales by Application
5.1.1 Global Rofecoxib Historical Sales by Application (2019-2024)
5.1.2 Global Rofecoxib Forecasted Sales by Application (2025-2030)
5.1.3 Global Rofecoxib Sales Market Share by Application (2019-2030)
5.2 Global Rofecoxib Revenue by Application
5.2.1 Global Rofecoxib Historical Revenue by Application (2019-2024)
5.2.2 Global Rofecoxib Forecasted Revenue by Application (2025-2030)
5.2.3 Global Rofecoxib Revenue Market Share by Application (2019-2030)
5.3 Global Rofecoxib Price by Application
5.3.1 Global Rofecoxib Price by Application (2019-2024)
5.3.2 Global Rofecoxib Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Rofecoxib Market Size by Type
6.1.1 US & Canada Rofecoxib Sales by Type (2019-2030)
6.1.2 US & Canada Rofecoxib Revenue by Type (2019-2030)
6.2 US & Canada Rofecoxib Market Size by Application
6.2.1 US & Canada Rofecoxib Sales by Application (2019-2030)
6.2.2 US & Canada Rofecoxib Revenue by Application (2019-2030)
6.3 US & Canada Rofecoxib Market Size by Country
6.3.1 US & Canada Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Rofecoxib Sales by Country (2019-2030)
6.3.3 US & Canada Rofecoxib Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rofecoxib Market Size by Type
7.1.1 Europe Rofecoxib Sales by Type (2019-2030)
7.1.2 Europe Rofecoxib Revenue by Type (2019-2030)
7.2 Europe Rofecoxib Market Size by Application
7.2.1 Europe Rofecoxib Sales by Application (2019-2030)
7.2.2 Europe Rofecoxib Revenue by Application (2019-2030)
7.3 Europe Rofecoxib Market Size by Country
7.3.1 Europe Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Rofecoxib Sales by Country (2019-2030)
7.3.3 Europe Rofecoxib Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rofecoxib Market Size
8.1.1 China Rofecoxib Sales (2019-2030)
8.1.2 China Rofecoxib Revenue (2019-2030)
8.2 China Rofecoxib Market Size by Application
8.2.1 China Rofecoxib Sales by Application (2019-2030)
8.2.2 China Rofecoxib Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rofecoxib Market Size by Type
9.1.1 Asia Rofecoxib Sales by Type (2019-2030)
9.1.2 Asia Rofecoxib Revenue by Type (2019-2030)
9.2 Asia Rofecoxib Market Size by Application
9.2.1 Asia Rofecoxib Sales by Application (2019-2030)
9.2.2 Asia Rofecoxib Revenue by Application (2019-2030)
9.3 Asia Rofecoxib Sales by Region
9.3.1 Asia Rofecoxib Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Rofecoxib Revenue by Region (2019-2030)
9.3.3 Asia Rofecoxib Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rofecoxib Market Size by Type
10.1.1 Middle East, Africa and Latin America Rofecoxib Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Rofecoxib Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Rofecoxib Market Size by Application
10.2.1 Middle East, Africa and Latin America Rofecoxib Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Rofecoxib Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Rofecoxib Sales by Country
10.3.1 Middle East, Africa and Latin America Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Rofecoxib Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Rofecoxib Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Chengdu Meinkai Chemical Co. LTD
11.2.1 Chengdu Meinkai Chemical Co. LTD Company Information
11.2.2 Chengdu Meinkai Chemical Co. LTD Overview
11.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Overview
11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Overview
11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Tremeau
11.6.1 Tremeau Company Information
11.6.2 Tremeau Overview
11.6.3 Tremeau Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Tremeau Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tremeau Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rofecoxib Industry Chain Analysis
12.2 Rofecoxib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rofecoxib Production Mode & Process
12.4 Rofecoxib Sales and Marketing
12.4.1 Rofecoxib Sales Channels
12.4.2 Rofecoxib Distributors
12.5 Rofecoxib Customers
13 Market Dynamics
13.1 Rofecoxib Industry Trends
13.2 Rofecoxib Market Drivers
13.3 Rofecoxib Market Challenges
13.4 Rofecoxib Market Restraints
14 Key Findings in The Global Rofecoxib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer Inc
Tremeau
List of Tables
    Table 1. Global Rofecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral Suspension.
    Table 3. Major Manufacturers of Tablet-Form
    Table 4. Global Rofecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Rofecoxib Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Rofecoxib Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Rofecoxib Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Rofecoxib Revenue Market Share by Region (2019-2024)
    Table 9. Global Rofecoxib Revenue Market Share by Region (2025-2030)
    Table 10. Global Rofecoxib Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Rofecoxib Sales by Region (2019-2024) & (K Units)
    Table 12. Global Rofecoxib Sales by Region (2025-2030) & (K Units)
    Table 13. Global Rofecoxib Sales Market Share by Region (2019-2024)
    Table 14. Global Rofecoxib Sales Market Share by Region (2025-2030)
    Table 15. Global Rofecoxib Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Rofecoxib Sales Share by Manufacturers (2019-2024)
    Table 17. Global Rofecoxib Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Rofecoxib Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Rofecoxib, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Rofecoxib Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Rofecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rofecoxib as of 2023)
    Table 23. Global Key Manufacturers of Rofecoxib, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Rofecoxib, Product Offered and Application
    Table 25. Global Key Manufacturers of Rofecoxib, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 28. Global Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 29. Global Rofecoxib Sales Share by Type (2019-2024)
    Table 30. Global Rofecoxib Sales Share by Type (2025-2030)
    Table 31. Global Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Rofecoxib Revenue Share by Type (2019-2024)
    Table 34. Global Rofecoxib Revenue Share by Type (2025-2030)
    Table 35. Rofecoxib Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Rofecoxib Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 38. Global Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 39. Global Rofecoxib Sales Share by Application (2019-2024)
    Table 40. Global Rofecoxib Sales Share by Application (2025-2030)
    Table 41. Global Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Rofecoxib Revenue Share by Application (2019-2024)
    Table 44. Global Rofecoxib Revenue Share by Application (2025-2030)
    Table 45. Rofecoxib Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Rofecoxib Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Rofecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Rofecoxib Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Rofecoxib Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Rofecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Rofecoxib Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Rofecoxib Sales by Country (2025-2030) & (K Units)
    Table 73. China Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 74. China Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 75. China Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 78. China Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 79. China Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Rofecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Rofecoxib Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Rofecoxib Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Rofecoxib Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Rofecoxib Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Rofecoxib Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Rofecoxib Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Rofecoxib Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Rofecoxib Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Rofecoxib Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Rofecoxib Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Rofecoxib Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Rofecoxib Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Rofecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Rofecoxib Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Rofecoxib Sales by Country (2025-2030) & (K Units)
    Table 107. Merck Company Information
    Table 108. Merck Description and Major Businesses
    Table 109. Merck Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Merck Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Merck Recent Developments
    Table 112. Chengdu Meinkai Chemical Co. LTD Company Information
    Table 113. Chengdu Meinkai Chemical Co. LTD Description and Major Businesses
    Table 114. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Chengdu Meinkai Chemical Co. LTD Recent Developments
    Table 117. Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
    Table 118. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Major Businesses
    Table 119. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
    Table 122. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
    Table 123. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Major Businesses
    Table 124. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
    Table 127. Pfizer Company Information
    Table 128. Pfizer Description and Major Businesses
    Table 129. Pfizer Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Pfizer Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Pfizer Recent Developments
    Table 132. Tremeau Company Information
    Table 133. Tremeau Description and Major Businesses
    Table 134. Tremeau Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Tremeau Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Tremeau Recent Developments
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Rofecoxib Distributors List
    Table 140. Rofecoxib Customers List
    Table 141. Rofecoxib Market Trends
    Table 142. Rofecoxib Market Drivers
    Table 143. Rofecoxib Market Challenges
    Table 144. Rofecoxib Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rofecoxib Product Picture
    Figure 2. Global Rofecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Rofecoxib Market Share by Type in 2023 & 2030
    Figure 4. Oral Suspension. Product Picture
    Figure 5. Tablet-Form Product Picture
    Figure 6. Global Rofecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Rofecoxib Market Share by Application in 2023 & 2030
    Figure 8. Osteoarthritis
    Figure 9. Rheumatoid Arthritis
    Figure 10. Juvenile Rheumatoid Arthritis
    Figure 11. Acute Pain Conditions
    Figure 12. Migraine
    Figure 13. Dysmenorrhea
    Figure 14. Rofecoxib Report Years Considered
    Figure 15. Global Rofecoxib Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Rofecoxib Revenue 2019-2030 (US$ Million)
    Figure 17. Global Rofecoxib Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Rofecoxib Revenue Market Share by Region (2019-2030)
    Figure 19. Global Rofecoxib Sales 2019-2030 ((K Units)
    Figure 20. Global Rofecoxib Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Rofecoxib Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada Rofecoxib Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Rofecoxib Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe Rofecoxib Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Rofecoxib Sales YoY (2019-2030) & (K Units)
    Figure 26. China Rofecoxib Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Rofecoxib Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) Rofecoxib Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Rofecoxib Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America Rofecoxib Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Rofecoxib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Rofecoxib in the World: Market Share by Rofecoxib Revenue in 2023
    Figure 33. Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 35. Global Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 36. Global Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 37. Global Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Rofecoxib Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Rofecoxib Sales Share by Country (2019-2030)
    Figure 44. U.S. Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 47. Europe Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 49. Europe Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Rofecoxib Revenue Share by Country (2019-2030)
    Figure 51. Europe Rofecoxib Sales Share by Country (2019-2030)
    Figure 52. Germany Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 53. France Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 57. China Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 58. China Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 59. China Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 60. China Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 62. Asia Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 64. Asia Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Rofecoxib Revenue Share by Region (2019-2030)
    Figure 66. Asia Rofecoxib Sales Share by Region (2019-2030)
    Figure 67. Japan Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 71. India Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Rofecoxib Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Rofecoxib Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Rofecoxib Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Rofecoxib Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Rofecoxib Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Rofecoxib Sales Share by Country (2019-2030)
    Figure 78. Brazil Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Rofecoxib Revenue (2019-2030) & (US$ Million)
    Figure 83. Rofecoxib Value Chain
    Figure 84. Rofecoxib Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Celecoxib Capsule Market Insights Forecast to 2030
Global Celecoxib Market Insights Forecast to 2030
Global Piroxicam Market Research Report 2024
Global Meloxicam Drugs Market Research Report 2024
Cox 2 Inhibitors Market
Global Carprofen Market Research Report 2025
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Reagent Grade Firocoxib Market Research Report 2024
Global Aceclofenac Market Research Report 2024
Global Lornoxicam Tablets Market Research Report 2024
Global Fenoprofen Calcium Market Research Report 2024
Global Ketoprofen Market Insights Forecast to 2030
Global Nimesulide Market Research Report 2024
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Loxoprofen Sodium Market Research Report 2024
Global Ketorolac Market Research Report 2024
Global Etoricoxib Market Research Report 2024
Global Piroxicam Patch Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions